Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
ketamine (ketalar) (1 trial)
Bipolar Disorder (Phase 3)
Disease (Phase 3)
Trials (1 total)
Trial APIs (1 total)